-
Vascular endothelial growth factor B-mediated fatty acid flux in the adipose-kidney axis contributes to lipotoxicity in diabetic kidney disease. Kidney Int. (IF 14.8) Pub Date : 2024-12-15 Erika Folestad,Annika Mehlem,Frank Chenfei Ning,Timo Oosterveld,Isolde Palombo,Jaskaran Singh,Hannes Olauson,Anna Witasp,Anders Thorell,Peter Stenvinkel,Kerstin Ebefors,Jenny Nyström,Ulf Eriksson,Annelie Falkevall
A common observation in diabetic kidney disease is lipid accumulation, but the mechanism(s) underlying this pathology is unknown. Inhibition of Vascular endothelial growth factor B (VEGF-B) signaling was shown to prevent glomerular lipid accumulation and ameliorated diabetic kidney disease in experimental models. Here, we examined kidney biopsies from patients with Type 2 (84 %) and Type 1 diabetes
-
The final frontier: kidney function, omics and deterioration in space Kidney Int. (IF 14.8) Pub Date : 2024-12-02 Vera C. Wulfmeyer, Marlus M. Rinschen
-
Corrigendum to "CD248 induces a maladaptive unfolded protein response in diabetic kidney disease." Kidney International 2023;103:304-319. Kidney Int. (IF 14.8) Pub Date : 2024-12-01 Shruthi Krishnan,Jayakumar Manoharan,Hongjie Wang,Dheerendra Gupta,Sameen Fatima,Yanfei Yu,Akash Mathew,Zhen Li,Shrey Kohli,Constantin Schwab,Antje Körner,Peter R Mertens,Peter Nawroth,Khurrum Shahzad,Michael Naumann,Berend Isermann,Ronald Biemann
-
Corrigendum to "Long-term impact of immediate versus deferred antiretroviral therapy on kidney health in people with HIV." Kidney International 2024;106:136-144. Kidney Int. (IF 14.8) Pub Date : 2024-12-01 Annegret Pelchen-Matthews,Amanda Mocroft,Lene Ryom,Michael J Ross,Shweta Sharma,Steven Coca,Amit Achhra,Elaine Cornell,Russell Tracy,Andrew Phillips,Marta Montero Alonso,Giota Toulomi,Brian K Agan,Nicholas Medland,Christina M Wyatt,
-
Chylothorax and chylopericardium in a dialysis patient. Kidney Int. (IF 14.8) Pub Date : 2024-12-01 Mohamad Hanouneh,Shelby Stewart,Recai Aktay,Adam S Fang,C Elena Cervantes
-
The Case | Acute kidney injury after endovascular aortic graft placement. Kidney Int. (IF 14.8) Pub Date : 2024-12-01 Sadia Saboor,Satoru Kudose,Miroslav Sekulic
-
Enhancing kidney organoid maturity with inducible vascularization: another step forward for in vitro modeling. Kidney Int. (IF 14.8) Pub Date : 2024-12-01 Lori L O'Brien
Kidney organoids represent a tangible in vitro system in which to model disease, identify novel therapeutics, and investigate cellular and physiological mechanisms. However, their relative immaturity and insufficient endowment of critical cell types limits their translational efficacy. Addressing a number of these shortcomings, Maggiore et al. present a novel genetically inducible vascularized kidney
-
Intravascular large B-cell-lymphoma: a rare post-transplant lymphoproliferative disease. Kidney Int. (IF 14.8) Pub Date : 2024-12-01 Ole Hudowenz,Niklas Gebauer
-
Tubular glycogen nuclei in a patient with glycogen storage disease type Ia. Kidney Int. (IF 14.8) Pub Date : 2024-12-01 Dandan Liang,Jing Liu,Ke Zuo,Erzhi Gao,Shaoshan Liang,Feng Xu,Caihong Zeng
-
Does the kidney influence the hunger for salt? Kidney Int. (IF 14.8) Pub Date : 2024-12-01 Matthew A Bailey
Sympathetic overactivation contributes to hypertension. Renal denervation can reduce blood pressure. In the deoxycorticosterone acetate (DOCA)-salt model of hypertension, salt consumption contributes to high blood pressure. A report in Kidney International finds selective ablation of renal sensory afferent nerves diminishes self-directed saline intake in the DOCA-salt rat. This suggests that these
-
Pretransplant biopsies for kidney allocation and discard: more questions than answers. Kidney Int. (IF 14.8) Pub Date : 2024-12-01 Karolien Wellekens,Maarten Naesens
-
Allocation biopsies of deceased donor kidneys: a necessary tool to expand the donor pool. Kidney Int. (IF 14.8) Pub Date : 2024-12-01 Syed Ali Husain,Sumit Mohan
-
Biopsy before transplant: optimizing allocation or fueling discard? Kidney Int. (IF 14.8) Pub Date : 2024-12-01 Griffith B Perkins
-
Misuse of the Cox proportional hazards model and alternative approaches in kidney outcome research. Kidney Int. (IF 14.8) Pub Date : 2024-12-01 Lingyu Xu,Yan Xu
-
Has APOL1 kidney disease treatment been hiding in plain sight? Kidney Int. (IF 14.8) Pub Date : 2024-12-01 Opeyemi A Olabisi
Two coding variants of APOL1 account for much of the excess risk of focal segmental glomerulosclerosis in people of recent West African ancestry. There is an unmet need of treatment for apolipoprotein L1 kidney disease. In this issue, Sula Karreci et al. reported that lisinopril reduced proteinuria and glomerulosclerosis in a mouse model of apolipoprotein L1-induced focal segmental glomerulosclerosis
-
New insights into mechanisms underlying cognitive impairment in chronic kidney disease. Kidney Int. (IF 14.8) Pub Date : 2024-12-01 Mickaël Bobot,Stéphane Burtey
Chronic kidney disease (CKD) is associated with an increased risk of cognitive impairment. Patients with CKD display an increased permeability of the blood-brain barrier. Zimmermann et al. highlighted the implication of potassium efflux in the microglia and its activation, the activation of the interleukin-1b/interleukin-1R pathway, linked to blood-brain barrier permeability and cognitive impairment
-
Oxalate nephropathy associated with glyoxylate-containing hair-straightening products: a call for caution. Kidney Int. (IF 14.8) Pub Date : 2024-12-01 Naim M Maalouf,Jonathan M Whittamore
Recent reports have described acute kidney injury in otherwise healthy individuals after exposure to hair-straightening products. In this issue, Robert et al. help elucidate the underlying mechanisms in a murine model that replicates the human pathology. Cutaneous absorption of glyoxylic acid from hair-straightening products and its subsequent conversion to oxalate are identified as crucial steps in
-
Purinergic receptor P2X7 regulates interleukin-1α mediated inflammation in chronic kidney disease in a reactive oxygen species-dependent manner Kidney Int. (IF 14.8) Pub Date : 2024-11-20 Maryam Amini, Janina Frisch, Priska Jost, Tamim Sarakpi, Simina-Ramona Selejan, Ellen Becker, Alexander Sellier, Jutta Engel, Michael Böhm, Mathias Hohl, Heidi Noels, Christoph Maack, Stefan Schunk, Leticia Prates Roma, Barbara A. Niemeyer, Thimoteus Speer, Dalia Alansary
Onset, progression and cardiovascular outcome of chronic kidney disease (CKD) are influenced by the concomitant sterile inflammation. The pro-inflammatory cytokine family interleukin (IL)-1 is crucial in CKD with the key alarmin IL-1α playing an additional role as an adhesion molecule that facilitates immune cell tissue infiltration and consequently inflammation. Here, we investigate calcium ion and
-
In situ molecular profiles of glomerular cells by integrated imaging mass spectrometry and multiplexed immunofluorescence microscopy Kidney Int. (IF 14.8) Pub Date : 2024-11-20 Allison B. Esselman, Felipe A. Moser, Léonore E.M. Tideman, Lukasz G. Migas, Katerina V. Djambazova, Madeline E. Colley, Ellie L. Pingry, Nathan Heath Patterson, Melissa A. Farrow, Haichun Yang, Agnes B. Fogo, Mark de Caestecker, Raf Van de Plas, Jeffrey M. Spraggins
Glomeruli filter blood through the coordination of podocytes, mesangial cells, fenestrated endothelial cells, and the glomerular basement membrane. Cellular changes, such as podocyte loss, are associated with pathologies like diabetic kidney disease. However, little is known regarding the in situ molecular profiles of specific cell types and how these profiles change with disease. Matrix-assisted laser
-
Challenges in maturation and integration of kidney organoids for stem cell–based renal replacement therapy Kidney Int. (IF 14.8) Pub Date : 2024-11-19 Cathelijne W. van den Berg, Sébastien J. Dumas, Melissa H. Little, Ton J. Rabelink
Human pluripotent stem cell–derived kidney organoids hold promise for future applications in regenerative medicine. However, significant biological hurdles need to be overcome to enable their use as a transplantable stem cell–derived therapeutic graft. Current kidney organoid protocols do not recapitulate a complete integrated developing kidney, but embryonic kidney transplantations have provided clues
-
The autoimmune architecture of childhood idiopathic nephrotic syndrome Kidney Int. (IF 14.8) Pub Date : 2024-11-19 Tho-Alfakar Al-Aubodah, Ciriaco A. Piccirillo, Howard Trachtman, Tomoko Takano
Idiopathic nephrotic syndrome, the most common glomerular disorder in children, has long been considered an immune-mediated disease based on the efficacy of glucocorticoids at inducing remission. Nevertheless, the immune processes leading to podocytopathy have largely remained elusive. The success of B-cell depletion with rituximab, descriptions of B-cell dysregulation during active disease, and the
-
TRAIL induces podocyte PANoptosis via death receptor 5 in diabetic kidney disease Kidney Int. (IF 14.8) Pub Date : 2024-11-19 Zhimei Lv, Jinxiu Hu, Hong Su, Qun Yu, Yating Lang, Meilin Yang, Xiaoting Fan, Yue Liu, Bing Liu, Yanfang Zhao, Cheng Wang, Shangwei Lu, Ning Shen, Rong Wang
Podocytes can undergo PANoptosis (apoptosis, pyroptosis, and necroptosis). Diabetic kidney disease (DKD) is the leading cause of kidney failure, and podocyte loss is a major event leading to the progression of DKD. Here, we compared single cell RNA sequencing (scRNA-seq) data between three normal and three DKD human kidney samples and found a significant increase of TNFSF10 and TNFRSF10B expression
-
Activating soluble guanylyl cyclase attenuates ischemic kidney damage Kidney Int. (IF 14.8) Pub Date : 2024-11-19 Falk-Bach Lichtenberger, Minze Xu, Cem Erdoğan, Lingyan Fei, Ilka Mathar, Lisa Dietz, Peter Sandner, Erdmann Seeliger, Sengül Boral, Julia Sophie Bonk, Tobias Sieckmann, Pontus B. Persson, Andreas Patzak, Kathleen Cantow, Pratik H. Khedkar
Can direct activation of soluble guanylyl cyclase (sGC) provide kidney-protection? To answer this, we tested the kidney-protective effects of a sGC activator, which functions independent of nitric oxide and with oxidized sGC, in an acute kidney injury (AKI) model with transition to chronic kidney disease (CKD). We hypothesize this treatment would provide protection of kidney microvasculature, kidney
-
Semaglutide and kidney function: direct kidney protection or an artifact? Kidney Int. (IF 14.8) Pub Date : 2024-11-19 Isabelle Ayoub, Germaine Wong, Richard J. Glassock
-
The critical role of endoplasmic reticulum stress and the stimulator of interferon genes (STING) pathway in kidney fibrosis Kidney Int. (IF 14.8) Pub Date : 2024-11-19 Magaiver Andrade-Silva, Poonam Dhillon, Andrea Sanchez-Navarro, Dhanunjay Mukhi, Hailong Hu, Lakshmi P. Kolligundla, Andrea Bergeson, Amin Abedini, Jonathan Levinsohn, Bernhard Dumoulin, Niels O.S. Câmara, Jonathan J. Miner, Katalin Susztak
Endoplasmic reticulum (ER) stress is a condition in which the ER is overwhelmed and unable to manage its protein load properly. The precise activation mechanisms and role of ER stress in kidney disease remain unclear. To study this, we performed unbiased transcriptomics analysis to demonstrate ER stress in kidneys of patients with chronic kidney disease and in mouse models of acute and chronic kidney
-
PI3Kα in the pathogenesis and treatment of lupus nephritis Kidney Int. (IF 14.8) Pub Date : 2024-11-17 Vivek Kasinath, George C. Tsokos
-
Advancing anti-inflammatory therapies: leveraging glucocorticoid pathways for novel treatments Kidney Int. (IF 14.8) Pub Date : 2024-11-16 Valerie Etzrodt, Huihui Huang, Samir M. Parikh
-
Post-hoc analysis of the CARES trial suggests delayed progression of chronic kidney disease in patients with gout during urate-lowering therapy Kidney Int. (IF 14.8) Pub Date : 2024-11-16 Byeongzu Ghang, Jino Park, Ji Sung Lee, Joon Seo Lim, Hyunwoo Kim, David F.L. Liew, Jinseok Kim, Duk-Hee Kang, Bin Yoo
Based on the hypothesis that hyperuricemia is a modifiable risk factor for chronic kidney disease (CKD) progression, there is an expectation that urate-lowering therapy (ULT) could delay the progression of CKD. Here, we investigated changes in kidney function and the association of the serum uric acid (sUA) level and kidney function during ULT in patients with gout. To do this we conducted post-hoc
-
A randomized controlled trial evaluated the efficacy and safety of apixaban for prevention of recurrent thrombosis after thrombectomy of hemodialysis vascular access Kidney Int. (IF 14.8) Pub Date : 2024-11-16 Tsung-Yu Ko, Chih-Cheng Wu, Mu-Yang Hsieh, Chung-Wei Yang, Chi-Hung Cheng, Chun-Kai Chen, Hsien-Li Kao
Dialysis vascular access thrombosis poses a substantial challenge for individuals undergoing hemodialysis. The efficacy and safety of apixaban, a direct oral coagulation factor Xa inhibitor, in preventing recurrent access thrombosis have yet to be explored. Here, a multicenter randomized control study (NCT04489849) enrolled hemodialysis patients to evaluate this who underwent successful endovascular
-
Lupus nephritis: redefining the treatment goals Kidney Int. (IF 14.8) Pub Date : 2024-11-08 An S. De Vriese, Sanjeev Sethi, Fernando C. Fervenza
The course of proliferative lupus nephritis is characterized by flares of activity alternating with periods of quiescence against a background of chronic immune dysregulation. An accurate assessment of disease activity is of unassailable importance to tailor therapy. In the present communication, we discuss the available clinical, serologic, and histologic tools to evaluate disease activity and how
-
Unlocking the potential of extracellular vesicles in nephrology: what does MISEV2023 add? Kidney Int. (IF 14.8) Pub Date : 2024-11-06 Monica Suet Ying Ng, Dylan Burger, Per Svenningsen, Elena Martens, Uta Erdbrügger, Fabian Braun
Extracellular vesicles, small membrane-bound packages secreted by virtually all cells of the body, have become a focus of interest in nephrology over the recent years. After the first characterization of their proteomic and transcriptomic content, scientific attention shifted toward their potential as biomarkers for kidney diseases both as diagnostic and monitoring tools. More recently, researchers
-
Evaluating the risk of cardiovascular events associated with different immunosuppression treatments for glomerular diseases Kidney Int. (IF 14.8) Pub Date : 2024-11-06 Mark Canney, Mohammad Atiquzzaman, Yuyan Zheng, Dilshani Induruwage, Yinshan Zhao, Lee Er, Christopher B. Fordyce, Sean J. Barbour
Patients with glomerular disease are at high risk of cardiovascular disease but the contribution of immunosuppression to this risk is unclear. In this retrospective cohort study of 1912 patients (comprised of 759 with IgA nephropathy, 540 with focal segmental glomerulosclerosis, 387 with membranous nephropathy and 226 with minimal change disease) from British Columbia, Canada, we evaluated the association
-
The glomerular circadian clock temporally regulates basement membrane dynamics and the podocyte glucocorticoid response Kidney Int. (IF 14.8) Pub Date : 2024-11-06 Rebecca Preston, Ruby Chrisp, Michal Dudek, Mychel R.P.T. Morais, Pinyuan Tian, Emily Williams, Richard W. Naylor, Bernard Davenport, Dharshika R.J. Pathiranage, Emma Benson, David G. Spiller, James Bagnall, Leo Zeef, Craig Lawless, Syed Murtuza Baker, Qing-Jun Meng, Rachel Lennon
Kidney physiology shows diurnal variation, and a disrupted circadian rhythm is associated with kidney disease. However, it remains largely unknown whether glomeruli, the filtering units in the kidney, are under circadian control. Here, we investigated core circadian clock components in glomeruli, together with their rhythmic targets and modes of regulation. With clock gene reporter mice, cell-autonomous
-
Female sex hormones inversely regulate acute kidney disease susceptibility throughout life. Kidney Int. (IF 14.8) Pub Date : 2024-11-01 Yuichiro Kitai,Naoya Toriu,Takahisa Yoshikawa,Yoshiki Sahara,Sonoko Kinjo,Yoko Shimizu,Yuki Sato,Akiko Oguchi,Ryo Yamada,Makiko Kondo,Eiichiro Uchino,Keisuke Taniguchi,Hiroyuki Arai,Takayoshi Sasako,Hironori Haga,Shingo Fukuma,Naoto Kubota,Takashi Kadowaki,Minoru Takasato,Yasuhiro Murakawa,Motoko Yanagita
While epidemiological and experimental studies have demonstrated kidney-protective effects of estrogen and female sex in adulthood, some epidemiological data showed deterioration of kidney function during puberty when estrogen production increases. However, molecular mechanisms explaining these conflicting phenomena remain unknown. Here, we showed that the pubertal sex hormone surge in female mice
-
Amoxicillin crystalluria and amoxicillin-induced crystal nephropathy: a narrative review Kidney Int. (IF 14.8) Pub Date : 2024-10-28 Dominique Vodovar, Cyril Mousseaux, Michel Daudon, Matthieu Jamme, Emmanuel Letavernier
Amoxicillin crystalluria (AC) refers to the precipitation of amoxicillin in the urine as amoxicillin trihydrate crystals. Amoxicillin-induced crystal nephropathy (AICN) refers to the obstruction of kidney tubules by amoxicillin trihydrate crystals, resulting in acute kidney injury. Usually considered rare and not serious, AC and AICN would be more frequent in patients receiving high-dose i.v. amoxicillin
-
Insights from the BKEVER Trial comparing everolimus versus mycophenolate mofetil for BK Polyomavirus infection in kidney transplant recipients Kidney Int. (IF 14.8) Pub Date : 2024-10-28 Sophie Caillard, Nicolas Meyer, Morgane Solis, Dominique Bertrand, Maite Jaureguy, Dany Anglicheau, Laure Ecotiere, Matthias Buchler, Nicolas Bouvier, Betoul Schvartz, Jean Philippe Rerolle, Anne Elisabeth Heng, Lionel Couzi, Agnes Duveau, Emmanuel Morelon, Yann LeMeur, Léonard Golbin, Eric Thervet, Ilies Benotmane, Samira Fafi-Kremer
The MTOR inhibitors have demonstrated antiviral properties, and prior non-randomized studies have suggested they may have a suppressive effect on BKPyV replication. Here, in this randomized, multicenter, controlled trial (BKEVER study), we sought to evaluate the impact of everolimus (EVR) in facilitating the clearance of BKPyV compared to simply reducing immunosuppression among kidney transplant recipients
-
Prenatal and preimplantation genetic testing for monogenic kidney disorders Kidney Int. (IF 14.8) Pub Date : 2024-10-28 Nine V.A.M. Knoers
In recent years, advances in genetic sequencing techniques and in the analysis of sequencing data have significantly improved our ability to diagnose genetic kidney diseases. Identification of the disease-causing genetic variant(s) is crucial not only for prognostication and personalized management, but also for providing genetic counseling and guiding family planning decisions. It is particularly
-
Sex dimorphism in kidney health and disease: mechanistic insights and clinical implication Kidney Int. (IF 14.8) Pub Date : 2024-10-28 Stefanie Steiger, Li Li, Annette Bruchfeld, Kate I. Stevens, Sarah M. Moran, Jürgen Floege, Fernando Caravaca-Fontán, Safak Mirioglu, Onno Y.K. Teng, Eleni Frangou, Andreas Kronbichler, Immunonephrology Working Group (IWG) of the European Renal Association (ERA)
Sex is a key variable in the regulation of human physiology and pathology. Many diseases disproportionately affect one sex: autoimmune diseases, such as systemic lupus erythematosus, are more common in women but more severe in men, whereas the incidence of other disorders such as gouty arthritis and malignant cancers is higher in men. Besides the pathophysiology, sex may also influence the efficacy
-
Avoiding arrythmias by personalizing the dialysate concentration: a case for precision medicine in patients on dialysis Kidney Int. (IF 14.8) Pub Date : 2024-10-26 T. Alp Ikizler, Tilman B. Drueke, Jürgen Floege, Germaine Wong
Cardiac arrythmias are common in patients undergoing maintenance hemodialysis. In this issue, Charytan et al. showed that in patients with hyperkalemia (serum potassium concentration 5.1–6.5 mEq/l) on hemodialysis, a dialysate concentration of 3 mEq/l combined with sodium zirconium cyclosilicate on dialysis-free days is associated with a low frequency of atrial fibrillation compared with a dialysate
-
Effects of dialysate potassium concentration of 3.0mEq/l with sodium zirconium cyclosilicate on dialysis-free days versus dialysate potassium concentration of 2.0mEq/l alone on rates of cardiac arrhythmias in hemodialysis patients with hyperkalemia Kidney Int. (IF 14.8) Pub Date : 2024-10-26 David M. Charytan, Wolfgang C. Winkelmayer, Christopher B. Granger, John P. Middleton, Charles A. Herzog, Glenn M. Chertow, James M. Eudicone, Jeremy D. Whitson, James A. Tumlin, ADAPT Investigators
The optimal approach towards managing serum potassium and hemodialysate potassium concentrations is uncertain. To study this, adults receiving hemodialysis for three months or more with hyperkalemia (pre-dialysis serum potassium (sK+) 5.1–6.5 mEq/l) had cardiac monitors implanted and were randomized to either eight weeks of 2.0 potassium/2.5 calcium mEq/l dialysate without sodium zirconium cyclosilicate
-
Higher intraoperative blood pressure does not reduce acute kidney injury in noncardiac surgery: what do the results of the POISE-3 trial tell us? Kidney Int. (IF 14.8) Pub Date : 2024-10-25 Nicholas M. Selby, Lui G. Forni
Hypotension is a common cause of acute kidney injury (AKI), with strong associations between the duration and magnitude of hypotension seen across a range of situations including major surgery. However, it is less clear whether targeting higher intraoperative MAP results in lower rates of AKI. In a prespecified analysis of the Perioperative Ischemic Evaluation-3 (POISE-3) randomized controlled trial
-
A sub-study of the POISE-3 randomized trial examined effects of a perioperative hypotension-avoidance strategy versus a hypertension-avoidance strategy on the risk of acute kidney injury Kidney Int. (IF 14.8) Pub Date : 2024-10-25 POISE-3 Trial Investigators and Study Groups, Amit X. Garg, Maura Marcucci, Meaghan S. Cuerden, Jessica M. Sontrop, Thomas W. Painter, Vladimir Lomivorotov, Daniel I. Sessler, Matthew T.V. Chan, Flavia K. Borges, Kate Leslie, Emmanuelle Duceppe, Chirag R. Parikh, Pavel Roshanov, María José Martínez-Zapata, Chew Yin Wang, Denis Xavier, Sergey Efremov, Giovanni Landoni, Ydo V. Kleinlugtenbelt, Wojciech
In this pre-specified sub-study of the POISE-3 trial, we examined the effect of a perioperative hypotension-avoidance strategy versus a hypertension-avoidance strategy on the risk of postoperative acute kidney injury (AKI). Altogether, 7307 patients were included from 110 hospitals in 22 countries. Patients were 45 years and older, had or were at risk of atherosclerotic disease, took at least one antihypertensive
-
Presentation and outcome in carriers of pathogenic variants in SLC34A1 and SLC34A3 encoding sodium-phosphate transporter NPT 2a and 2c Kidney Int. (IF 14.8) Pub Date : 2024-10-24 Max Brunkhorst, Lena Brunkhorst, Helge Martens, Svetlana Papizh, Martine Besouw, Corinna Grasemann, Serap Turan, Przemyslaw Sikora, Milan Chromek, Elisabeth Cornelissen, Marc Fila, Marc Lilien, Jeremy Allgrove, Thomas J. Neuhaus, Mehmet Eltan, Laura Espinosa, Dirk Schnabel, Ibrahim Gokce, Juan David González-Rodríguez, Priyanka Khandelwal, Mandy G. Keijzer-Veen, Felix Lechner, Maria Szczepańska, Marcin
Pathogenic variants in SLC34A1 and SLC34A3 encoding sodium-phosphate transporter 2a and 2c are rare causes of phosphate wasting. Since data on presentation and outcomes are scarce, we collected clinical, biochemical and genetic data via an online questionnaire and the support of European professional organizations. One hundred thirteen patients (86% children) from 90 families and 17 countries with
-
PCDH7-antibodies and PCDH7 immune deposits are mostly found in patients with PLA2R1- or NELL1-associated membranous nephropathy Kidney Int. (IF 14.8) Pub Date : 2024-10-24 Maya Machalitza, Hanna Debiec, Benedikt Krümpelmann, Nicoletta Ferru, Muhammed Elyesa Kilictas, Tobias B. Huber, Linda Reinhard, Thorsten Wiech, Pierre Ronco, Elion Hoxha
-
An observational cohort study of kidney function evolution following increased BK viral replication Kidney Int. (IF 14.8) Pub Date : 2024-10-24 Evert Cleenders, Maarten Coemans, Olga Mineeva-Sangwo, Priyanka Koshy, Dirk Kuypers, Geert Verbeke, Maarten Naesens
-
Diagnosis and management of immune checkpoint inhibitor–associated nephrotoxicity: a position statement from the American Society of Onco-nephrology Kidney Int. (IF 14.8) Pub Date : 2024-10-24 Sandra M. Herrmann, Ala Abudayyeh, Shruti Gupta, Prakash Gudsoorkar, Nattawat Klomjit, Shveta S. Motwani, Sabine Karam, Verônica T. Costa E Silva, Sheikh B. Khalid, Shuchi Anand, Jaya Kala, David E. Leaf, Naoka Murakami, Arash Rashidi, Rimda Wanchoo, Abhijat Kitchlu
Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of cancer and are now the backbone of therapy for several malignancies. However, ICIs can cause a spectrum of renal immune-related adverse events including acute kidney injury (AKI), most commonly manifesting as acute interstitial nephritis (AIN), although glomerular disease and electrolyte disturbances have also been reported. In
-
Urinary casts containing crystals in light chain proximal tubulopathy. Kidney Int. (IF 14.8) Pub Date : 2024-11-01 Yusuke Ushio,Takashi Yokoyama,Shun Manabe,Momoko Seki,Yuki Kawaguchi,Shizuka Kobayashi,Shiho Makabe,Hiroshi Seino,Naoko Ito,Hideki Nakayama,Shigeru Horita,Hiroshi Kataoka,Sekiko Taneda,Kazuho Honda,Junichi Hoshino
-
Kidney failure and a reticulated dermatosis. Kidney Int. (IF 14.8) Pub Date : 2024-11-01 Bastian Robinson Baarz,Julia Huynh,Felix Constantin Heuschert,Kai-Uwe Eckardt,Julia Bontscho
-
Recurrent iodine-induced sialadenitis in a patient undergoing hemodialysis: is this really ineluctable? Kidney Int. (IF 14.8) Pub Date : 2024-11-01 Hélène Georgery,Jean-Philippe Lengelé,Sophie Leflot,Valentine Gillion
-
Hyponatremia associated with acute intermittent porphyria. Kidney Int. (IF 14.8) Pub Date : 2024-11-01 Dietmar Schiller,Caroline Schmitt,Ina Söllradl,Alexander Ziachehabi
-
Dialysis modality and quality of life: more answers yet more questions. Kidney Int. (IF 14.8) Pub Date : 2024-11-01 Hiba Hamdan,Baback Roshanravan
Persons with end-stage kidney disease treated with dialysis experience distressing reductions in quality of life and increased mortality. Few large, randomized trials in nephrology have reported on health-related quality of life. Rose et al. report beneficial effects of high-volume hemodiafiltration versus high-flux hemodialysis on secondary end points of health-related quality of life in the CONVINCE
-
Corrigendum to "Acute kidney injury genetic risks: taking it 1 SNP at a time." Kidney International 2024;106:188-190. Kidney Int. (IF 14.8) Pub Date : 2024-11-01 Ian B Stanaway,Pavan K Bhatraju,Jonathan Himmelfarb
-
Using prediction models to improve care and communicate risk: updated modeling for children with IgA nephropathy. Kidney Int. (IF 14.8) Pub Date : 2024-11-01 Nicholas G Larkins,Jonathan C Craig
Clinical risk prediction models are being generated at an increasing rate. One important component is the identification of groups for whom such models might require recalibration to retain their desired performance. To this end, an update of the postbiopsy International IgA Nephropathy Prediction Tool for children has been published in this issue of Kidney International. We review the methods used
-
Corrigendum to "Early treatment with xenon protects against the cold ischemia associated with chronic allograft nephropathy in rats." Kidney International 2013;85:112-123. Kidney Int. (IF 14.8) Pub Date : 2024-11-01 Hailin Zhao,Xianghong Luo,Zhaowei Zhou,Juying Liu,Catherine Tralau-Stewart,Andrew J T George,Daqing Ma
-
Looking into the cholesterol crystal ball: is complement the answer? Kidney Int. (IF 14.8) Pub Date : 2024-11-01 Marina Noris,Giuseppe Remuzzi
Cholesterol crystal embolism (CCE) is a complication of atherosclerosis and can cause microvascular obstruction in multiple organs. Because the consequences may be fatal, and there is no specific treatment, it is crucial to understand the mechanisms and identify treatment strategies. In this issue, Zhao et al., using a mouse model of kidney CCE, demonstrated that inhibition of C5a/C5aR prevented and
-
Patients with crush syndrome and kidney disease: lessons learned from the earthquake in Kahramanmaraş, Türkiye. Kidney Int. (IF 14.8) Pub Date : 2024-11-01 Savas Ozturk,Serhan Tuglular,Refik Olmaz,Ismail Kocyigit,Muge Uzerk Kibar,Kenan Turgutalp,Dilek Torun,Tuncay Sahutoglu,Ozlem Usalan,Ozkan Gungor,Ramazan Danis,Gursel Yildiz,Ali Gurel,Mehmet Horoz,Mehmet Kucuksu,Suleyman Karakose,Tolga Yildirim,Mehmet Riza Altiparmak,Mehmet Deniz Ayli,Murat Tugcu,Zehra Eren,Eray Eroglu,Yasemin Coskun Yavuz,Esra Akcali,Dede Sit,Mehmet Polat,Saliha Yildirim,Selma Alagoz
This study investigated in-hospital outcomes and related factors in patients diagnosed with postearthquake crush syndrome after the earthquakes in Kahramanmaraş, Türkiye. One thousand twenty-four adult patients diagnosed with crush syndrome were analyzed. Data on demographic characteristics, clinical presentation, laboratory values, treatments, and outcomes were collected. A total of 9.8% of patients
-
Appendicitis associated with sevelamer use in a patient receiving peritoneal dialysis. Kidney Int. (IF 14.8) Pub Date : 2024-11-01 Zan Shareef,Merry Spradling,Pamela Blair,Irmaris Quiñones-Vargas,Namita Singh,Darren Schmidt,Jain Zhou,Pablo Garcia
-
An international, multi-center study evaluated rituximab therapy in childhood steroid-resistant nephrotic syndrome Kidney Int. (IF 14.8) Pub Date : 2024-10-10 Eugene Yu-hin Chan, Aditi Sinha, Ellen L.M. Yu, Naureen Akhtar, Andrea Angeletti, Arvind Bagga, Sushmita Banerjee, Olivia Boyer, Chang-Yien Chan, Anna Francis, Gian Marco Ghiggeri, Riku Hamada, Pankaj Hari, Nakysa Hooman, Luke Sydney Hopf, Mohamad Ikram I, Iftikhar Ijaz, Dmytro D. Ivanov, Suprita Kalra, Hee Gyung Kang, Laura Lucchetti, Francesca Lugani, Alison Lap-tak Ma, William Morello, María Dolores
The efficacy and safety of rituximab in childhood steroid-resistant nephrotic syndrome (SRNS) remains unclear. Therefore, we conducted a retrospective cohort study at 28 pediatric nephrology centers from 19 countries in Asia, Europe, North America and Oceania to evaluate this. Children with SRNS treated with rituximab were analyzed according to the duration of calcineurin inhibitors (CNIs) treatment
-
Outcomes from the International Society of Nephrology Hemolytic Uremic Syndromes International Forum Kidney Int. (IF 14.8) Pub Date : 2024-10-10 David Kavanagh, Gianluigi Ardissino, Vicky Brocklebank, Romy N. Bouwmeester, Arvind Bagga, Rob ter Heine, Sally Johnson, Christoph Licht, Alison L.T. Ma, Marina Noris, Manuel Praga, Eric Rondeau, Aditi Sinha, Richard J.H. Smith, Neil S. Sheerin, H. Trimarchi, Jack F.M. Wetzels, Marina Vivarelli, Nicole C.A.J. Van de Kar, Larry A. Greenbaum, Forum Participants, Adrian Catalin Lungu, Aleksandra Żurowska
Hemolytic uremic syndromes (HUSs) are a heterogeneous group of conditions, only some of which are mediated by complement (complement-mediated HUS). We report the outcome of the 2023 International Society of Nephrology HUS International Forum where a global panel of experts considered the current state of the art, identified areas of uncertainty, and proposed optimal solutions. Areas of uncertainty
-
Suppression of aldehyde dehydrogenase 2 in kidney proximal tubules contributes to kidney fibrosis through Transforming Growth Factor-β signaling Kidney Int. (IF 14.8) Pub Date : 2024-10-10 I-Jen Chiu, Amrendra K. Ajay, Che-Hong Chen, Shreyas Jadhav, Li Zhao, Minghua Cao, Yan Ding, Kavya M. Shah, Sujal I. Shah, Li-Li Hsiao
Chronic kidney disease (CKD) is an increasingly prevalent disorder that poses a significant global health and socioeconomic burden. East Asian countries such as China, Taiwan, Japan, and South Korea have a higher incidence and prevalence of kidney failure when compared to Western nations, and the reasons for this discrepancy remain unclear. Aldehyde dehydrogenase 2 (ALDH2) is an essential detoxifying